CHRISTINA GRAHAM: Open Payments
NPI 1689214108 · POWHATAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 57 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $47 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $145 |
| Astellas Pharma US Inc | 2 | $126 |
| Lilly USA, LLC | 5 | $93 |
| Novo Nordisk Inc | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 5 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $62 |
| Amgen Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
Products named: Veozah, JARDIANCE, VRAYLAR, MOUNJARO, UBRELVY, Ozempic, Kerendia, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
